All News #Library
Rare Diseases
LEO Pharma Strengthens Rare Skin Disease Focus With Replay Gene
30 Apr 2026 //
PHARMIWEB
JPM26: Leo Pharma Sharpens Its Eye For Dermatology Dealmaking
13 Jan 2026 //
FIERCE PHARMA
First-Of-Its-Kind Cream For Chronic Hand Eczema Patients On NHS
05 Nov 2025 //
PHARMIWEB
Leo Ponies up €90 Million for Boehringer Ingelheim`s Spevigo
15 Jul 2025 //
BUSINESSWIRE
Leo Pharma spending $14M upfront to acquire Timber
21 Aug 2023 //
ENDPTS
Sanifit touts positive PhIIb data; REGENXBIO licenses Clearside Biomedical tech
31 Oct 2019 //
ENDPTS

Market Place
Sourcing Support